• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人含黄素单加氧酶同工型2(FMO2.1)变体S195L和N413K的硫氧化特征及结构影响

Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.

作者信息

Krueger Sharon K, Henderson Marilyn C, Siddens Lisbeth K, VanDyke Jonathan E, Benninghoff Abby D, Karplus P Andrew, Furnes Bjarte, Schlenk Daniel, Williams David E

机构信息

Linus Pauling Institute, Oregon State University, Corvallis, OR 97331, USA.

出版信息

Drug Metab Dispos. 2009 Aug;37(8):1785-91. doi: 10.1124/dmd.109.027201. Epub 2009 May 6.

DOI:10.1124/dmd.109.027201
PMID:19420133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2712441/
Abstract

Catalytically active human flavin-containing monooxygenase isoform 2 (FMO2.1) is encoded by an allele detected only in individuals of African or Hispanic origin. Genotyping and haplotyping studies indicate that S195L and N413K occasionally occur secondary to the functional FMO21 allele encoding reference protein Gln472. Sulfoxygenation under a range of conditions reveals the role these alterations may play in individuals expressing active FMO2 and provides insight into FMO structure. Expressed S195L lost rather than gained activity as pH was increased or when cholate was present. The activity of S195L was mostly eliminated after heating at 45 degrees C for 5 min in the absence of NADPH, but activity was preserved if NADPH was present. By contrast, Gln472 was less sensitive to heat, a response not affected by NADPH. A major consequence of the S195L mutation was a mean 12-fold increase in K(m) for NADPH compared with Gln472. Modeling an S213L substitution, the equivalent site, in the structural model of FMO from the Methylophaga bacterium leads to disruption of interactions with NADP(+). N413K had the same pattern of activity as Gln472 in response to pH, cholate, and magnesium, but product formation was always elevated by comparison. N413K also lost more activity when heated than Gln472; however, NADPH attenuated this loss. The major effects of N413K were increases in velocity and k(cat) compared with Gln472. Although these allelic variants are expected to occur infrequently as mutations to the FMO21 allele, they contribute to our overall understanding of mammalian FMO structure and function.

摘要

具有催化活性的人含黄素单加氧酶同工型2(FMO2.1)由仅在非洲裔或西班牙裔个体中检测到的一个等位基因编码。基因分型和单倍型研究表明,S195L和N413K偶尔会继发于编码参考蛋白Gln472的功能性FMO21等位基因。在一系列条件下的硫氧化反应揭示了这些改变可能在表达活性FMO2的个体中所起的作用,并为FMO结构提供了深入了解。随着pH值升高或存在胆酸盐时,表达的S195L失去而非获得活性。在不存在NADPH的情况下,S195L在45℃加热5分钟后活性大多被消除,但如果存在NADPH则活性得以保留。相比之下,Gln472对热不太敏感,这种反应不受NADPH影响。S195L突变的一个主要后果是与Gln472相比,NADPH的K(m)平均增加了12倍。在来自嗜甲基菌的FMO结构模型中模拟等效位点的S213L取代会导致与NADP(+)的相互作用中断。N413K在对pH、胆酸盐和镁的反应中具有与Gln472相同的活性模式,但相比之下产物形成总是升高。与Gln472相比,N413K在加热时也失去了更多活性;然而,NADPH减弱了这种损失。与Gln472相比,N413K的主要影响是速度和k(cat)增加。尽管预计这些等位基因变体作为FMO21等位基因的突变很少发生,但它们有助于我们对哺乳动物FMO结构和功能的整体理解。

相似文献

1
Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.人含黄素单加氧酶同工型2(FMO2.1)变体S195L和N413K的硫氧化特征及结构影响
Drug Metab Dispos. 2009 Aug;37(8):1785-91. doi: 10.1124/dmd.109.027201. Epub 2009 May 6.
2
Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide.哺乳动物黄素单加氧酶(FMO)作为过氧化氢的来源。
Biochem Pharmacol. 2014 May 1;89(1):141-7. doi: 10.1016/j.bcp.2014.02.006. Epub 2014 Feb 19.
3
Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.西班牙裔人群中四种含黄素单加氧酶同工酶2(FMO2)多态性的单倍型及功能分析。
Pharmacogenet Genomics. 2005 Apr;15(4):245-56. doi: 10.1097/01213011-200504000-00008.
4
Characterization of mouse flavin-containing monooxygenase transcript levels in lung and liver, and activity of expressed isoforms.小鼠肺和肝脏中含黄素单加氧酶转录水平的表征以及表达同工型的活性
Biochem Pharmacol. 2008 Jan 15;75(2):570-9. doi: 10.1016/j.bcp.2007.09.006. Epub 2007 Sep 8.
5
Sequencing, expression, and characterization of cDNA expressed flavin-containing monooxygenase 2 from mouse.小鼠含黄素单加氧酶2的cDNA测序、表达及特性分析
J Biochem Mol Toxicol. 2001;15(6):300-8. doi: 10.1002/jbt.10009.
6
Flavin-containing monooxygenase (FMO)-dependent metabolism of methionine and evidence for FMO3 being the major FMO involved in methionine sulfoxidation in rabbit liver and kidney microsomes.含黄素单加氧酶(FMO)依赖的蛋氨酸代谢以及FMO3作为兔肝脏和肾脏微粒体中参与蛋氨酸亚砜氧化的主要FMO的证据。
J Biol Chem. 1994 Jul 1;269(26):17525-30.
7
Differences in FMO2*1 allelic frequency between Hispanics of Puerto Rican and Mexican descent.波多黎各裔和墨西哥裔西班牙人的FMO2*1等位基因频率差异。
Drug Metab Dispos. 2004 Dec;32(12):1337-40. doi: 10.1124/dmd.104.001099. Epub 2004 Sep 8.
8
Characterization of expressed full-length and truncated FMO2 from rhesus monkey.
Drug Metab Dispos. 2001 May;29(5):693-700.
9
Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein.
Drug Metab Dispos. 2002 Jan;30(1):34-41. doi: 10.1124/dmd.30.1.34.
10
Structure and function of a flavin-dependent S-monooxygenase from garlic ().大蒜黄素依赖 S-单加氧酶的结构与功能。
J Biol Chem. 2020 Aug 7;295(32):11042-11055. doi: 10.1074/jbc.RA120.014484. Epub 2020 Jun 11.

引用本文的文献

1
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.选定的非 P450 人氧化还原酶在化学品的保护和毒性作用中的作用:反应的综述和汇编。
Arch Toxicol. 2022 Aug;96(8):2145-2246. doi: 10.1007/s00204-022-03304-3. Epub 2022 Jun 1.
2
Ancestral-sequence reconstruction unveils the structural basis of function in mammalian FMOs.祖先序列重建揭示了哺乳动物 FMO 功能的结构基础。
Nat Struct Mol Biol. 2020 Jan;27(1):14-24. doi: 10.1038/s41594-019-0347-2. Epub 2019 Dec 23.
3
Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide.哺乳动物黄素单加氧酶(FMO)作为过氧化氢的来源。
Biochem Pharmacol. 2014 May 1;89(1):141-7. doi: 10.1016/j.bcp.2014.02.006. Epub 2014 Feb 19.
4
Metabolism and pharmacokinetics of the anti-tuberculosis drug ethionamide in a flavin-containing monooxygenase null mouse.含黄素单加氧酶缺失小鼠体内抗结核药物乙硫异烟胺的代谢和药代动力学。
Pharmaceuticals (Basel). 2012;5(11):1147-59. doi: 10.3390/ph5111147.

本文引用的文献

1
Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamide.人含黄素单加氧酶2.1催化抗结核药物氨硫脲和乙硫异烟胺的氧化反应。
Drug Metab Dispos. 2009 Jan;37(1):178-86. doi: 10.1124/dmd.108.024158. Epub 2008 Oct 23.
2
Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes.抗结核药物乙硫异烟胺在小鼠和人类FMO1、FMO2和FMO3以及小鼠和人类肺微粒体中的代谢。
Toxicol Appl Pharmacol. 2008 Dec 15;233(3):420-7. doi: 10.1016/j.taap.2008.09.017. Epub 2008 Oct 1.
3
The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa.潜在有害的功能变异体含黄素单加氧酶2*1在撒哈拉以南非洲地区的出现频率很高。
Pharmacogenet Genomics. 2008 Oct;18(10):877-86. doi: 10.1097/FPC.0b013e3283097311.
4
Revealing the moonlighting role of NADP in the structure of a flavin-containing monooxygenase.揭示NADP在含黄素单加氧酶结构中的兼职作用。
Proc Natl Acad Sci U S A. 2008 May 6;105(18):6572-7. doi: 10.1073/pnas.0800859105. Epub 2008 Apr 28.
5
Flavin-containing monooxygenases: mutations, disease and drug response.含黄素单加氧酶:突变、疾病与药物反应。
Trends Pharmacol Sci. 2008 Jun;29(6):294-301. doi: 10.1016/j.tips.2008.03.004. Epub 2008 Apr 16.
6
Characterization of mouse flavin-containing monooxygenase transcript levels in lung and liver, and activity of expressed isoforms.小鼠肺和肝脏中含黄素单加氧酶转录水平的表征以及表达同工型的活性
Biochem Pharmacol. 2008 Jan 15;75(2):570-9. doi: 10.1016/j.bcp.2007.09.006. Epub 2007 Sep 8.
7
Clustal W and Clustal X version 2.0.Clustal W和Clustal X 2.0版本
Bioinformatics. 2007 Nov 1;23(21):2947-8. doi: 10.1093/bioinformatics/btm404. Epub 2007 Sep 10.
8
Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.与三甲胺尿症相关的人类FMO3基因变异的功能特征
Arch Biochem Biophys. 2007 Aug 15;464(2):251-9. doi: 10.1016/j.abb.2007.04.014. Epub 2007 May 2.
9
PTC124 targets genetic disorders caused by nonsense mutations.PTC124靶向由无义突变引起的遗传性疾病。
Nature. 2007 May 3;447(7140):87-91. doi: 10.1038/nature05756. Epub 2007 Apr 22.
10
Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants.常见人类含黄素单加氧酶3基因变异体的鉴定与功能分析
J Pharmacol Exp Ther. 2007 Jan;320(1):266-73. doi: 10.1124/jpet.106.112268. Epub 2006 Oct 18.